UnitedHealth Group shares fell 9.7% to $351.84 at 2 p.m. Eastern time on Wednesday, from Tuesday’s close of $389.68. Humana fell 11.4% to $392.64, from $443.34. Elevance Health was down 7.0%, CVS Health 3.9% and Cigna 2.8%. It was the second straight day of losses: on Tuesday, UnitedHealth closed down 5.4% and Humana down 3.9%. UnitedHealth’s drop also weighed on the Dow Jones Industrial Average, which was down 0.9%.
The selling followed a rule the Centers for Medicare & Medicaid Services proposed on Monday. Called CRUSH, short for Comprehensive Regulations to Uncover Suspicious Healthcare, it targets fraud across Medicare, Medicaid and the insurance marketplace. CMS said it could save taxpayers nearly $90 billion over 10 years.
The part that matters most to insurers is a tougher audit of private Medicare Advantage plans. CMS would check whether the diagnoses plans report, which raise the payments they receive, are backed by medical records. It would apply audit findings across whole contracts starting with payment year 2018, and estimates it would recover about $9 billion a year on average. It also proposes not to apply an adjustment that insurers had sought to reduce those recoveries.
A federal court in Texas threw out an earlier version of the audit rule in September 2025, and CMS is appealing. Oppenheimer analysts said they expect the new rule to face “the same legal challenges,” according to Yahoo Finance. Comments on the proposal are due Jan. 19, 2027.
Neither UnitedHealth nor Humana has filed a statement about the proposal with the Securities and Exchange Commission.
…
That’s the story. … Thank you for listening to Cedar Global Markets. We’re supported by our partners, and you can learn more about the partner featured on this page. We’ll see you next time.




